Cited by 931Tryptophan and brain disordersSchizophrenia research and treatmentNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

Open access

Khandaker, Golam M, Cousins, Lesley, Deakin, Julia, Lennox, Belinda R, Yolken, Robert, Jones, Peter B·2015·The Lancet Psychiatry

DOI 10.1016/s2215-0366(14)00122-9PMC PMC4595998

Open this paper in CoChat — free account

Abstract

Complex interactions between the immune system and the brain might have important aetiological and therapeutic implications for neuropsychiatric brain disorders. A possible association between schizophrenia and the immune system was postulated over a century ago, and is supported by epidemiological and genetic studies pointing to links with infection and inflammation. Contrary to the traditional view that the brain is an immunologically privileged site shielded behind the blood-brain barrier, studies in the past 20 years have noted complex interactions between the immune system, systemic inflammation, and the brain, which can lead to changes in mood, cognition, and behaviour. In this Review, we describe some of the important areas of research regarding innate and adaptive immune response in schizophrenia and related psychotic disorders that, we think, will be of interest to psychiatric clinicians and researchers. We discuss potential mechanisms and therapeutic implications of these findings, including studies of anti-inflammatory drugs in schizophrenia, describe areas for development, and offer testable hypotheses for future investigations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s2215-0366(14)00122-9

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Immunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,111
Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
J Neuropsychiatry Clin Neurosci
Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
Hsiao, E. Y., McBride, S. W., Hsien, S., Sharon, G., Hyde, E. R., McCue, T., Codelli, J. A., Chow, J., Reisman, S. E., Petrosino, J. F., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.024 · Cited by 3,283
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
Titulaer, M. J., McCracken, L., Gabilondo, I., Armangué, T., Glaser, C., Iizuka, T., Honig, L. S., Benseler, S. M., Kawachi, I., Martinez-Hernandez, E., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70310-1 · Cited by 3,165
Long-term cognitive impairment and functional disability among survivors of severe sepsis.
Iwashyna, T. J., Ely, E. W., Smith, D. M., & Langa, K. M. (2010) · JAMA · doi:10.1001/jama.2010.1553 · Cited by 2,582
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Dalmau, J. O., Lancaster, E., Martínez‐Hernández, E., Rosenfeld, M. R., & Balice‐Gordon, R. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70253-2 · Cited by 2,428
Microglial physiology: unique stimuli, specialized responses
Ransohoff, R. M., & Perry, V. H. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132528 · Cited by 1,858
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Risk of Cardiovascular Events Associated with Selective COX-2 Inhibitors
Mukherjee, D. (2001) · JAMA · doi:10.1001/jama.286.8.954 · Cited by 1,741
Common variants conferring risk of schizophrenia
†Genetic Risk and Outcome in Psychosis (GROUP), Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O. A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O. P. H., Mors, O., et al. (2009) · Nature · doi:10.1038/nature08186 · Cited by 1,677
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
De novo mutations in schizophrenia implicate synaptic networks
Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., Gormley, P., Georgieva, L., Rees, E., Palta, P., Ruderfer, D. M., et al. (2014) · Nature · doi:10.1038/nature12929 · Cited by 1,617
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression: The Role of Baseline Inflammatory Biomarkers
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
The interplay between the intestinal microbiota and the brain
Collins, S. M., Surette, M., & Bercik, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2876 · Cited by 1,611
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
Smith, S. E. P., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2178-07.2007 · Cited by 1,605
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Immune modulation of learning, memory, neural plasticity and neurogenesis
Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483
Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365
Prenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Brown, A. S., & Derkits, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030361 · Cited by 1,269
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Green, C. E., Perez, A. M., Iqbal, S., Pillemer, S., Foulkes, A., Shah, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13030392 · Cited by 1,205
Common variants on chromosome 6p22.1 are associated with schizophrenia
Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe’er, I., Dudbridge, F., Holmans, P., Whittemore, A. S., Mowry, B. J., et al. (2009) · Nature · doi:10.1038/nature08192 · Cited by 1,154
The Journal of Neuropsychiatry and Clinical Neurosciences
Bowden, V. M., & Bowden, C. (1992) · JAMA · doi:10.1001/jama.1992.03490110111047 · Cited by 1,106
Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression
Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J. F., & Dinan, T. G. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.08.005 · Cited by 999
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985
Neuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 949
Is schizophrenia a neurodevelopmental disorder?
Murray, R. M., & Lewis, S. W. (1988) · BMJ · doi:10.1136/bmj.296.6614.63 · Cited by 911
Is schizophrenia a neurodevelopmental disorder?
Murray, R. M., & Lewis, S. W. (1987) · BMJ · doi:10.1136/bmj.295.6600.681 · Cited by 889
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review
Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 858
Association of Serum Interleukin 6 and C-Reactive Protein in Childhood With Depression and Psychosis in Young Adult Life: A Population-Based Longitudinal Study
Khandaker, G. M., Pearson, R. M., Zammit, S., Lewis, G., & Jones, P. B. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1332 · Cited by 846
Self-citation
CNS immune privilege: hiding in plain sight
Carson, M. J., Doose, J. M., Melchior, B., Schmid, C. D., & Ploix, C. C. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00441.x · Cited by 838
The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction
Engelhardt, B., & Sorokin, L. M. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0177-0 · Cited by 792
Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity
Dantzer, R. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.040 · Cited by 743
Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review
Danesh, J., Kaptoge, S., Mann, A. G., Sarwar, N., Wood, A., Angleman, S. B., Wensley, F., Higgins, J. P. T., Lennon, L., Eiriksdottir, G., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050078 · Cited by 676
Elevated inflammation levels in depressed adults with a history of childhood maltreatment
Danese, A., Moffitt, T. E., Pariante, C. M., Ambler, A., Poulton, R., & Caspi, A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.409 · Cited by 641
Incidence of Schizophrenia and Other Psychoses in England, 1950–2009: A Systematic Review and Meta-Analyses
Kirkbride, J. B., Errázuriz, A., Croudace, T. J., Morgan, C., Jackson, D., Boydell, J. E., Murray, R. M., & Jones, P. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031660 · Cited by 588
Self-citation
Microglia Activation in Recent-Onset Schizophrenia: A Quantitative (R)-[11C]PK11195 Positron Emission Tomography Study
van Berckel, B. N. M., Bossong, M. G., Boellaard, R., Kloet, R. W., Schuitemaker, A., Caspers, E., Luurtsema, G., Windhorst, A. D., Cahn, W., Lammertsma, A. A., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.025 · Cited by 582
Autoimmune Diseases and Severe Infections as Risk Factors for Schizophrenia: A 30-Year Population-Based Register Study
Benros, M. E., Nielsen, P. R., Nordentoft, M., Eaton, W. W., Dalton, S. O., & Mortensen, P. B. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11030516 · Cited by 582
Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study
Davis, D. H. J., Terrera, G. M., Keage, H. A. D., Rahkonen, T., Oinas, M., Matthews, F. E., Cunningham, C. M., Polvikoski, T. M., Sulkava, R. O., MacLullich, A. M. J., et al. (2012) · Brain · doi:10.1093/brain/aws190 · Cited by 570
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
Doorduin, J., de Vries, E. F. J., Willemsen, A. T. M., de Groot, J. C., Dierckx, R., & Klein, H. C. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.066647 · Cited by 561
Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities
Schwarcz, R. M., & Pellicciari, R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034439 · Cited by 556
Association of Schizophrenia and Autoimmune Diseases: Linkage of Danish National Registers
Eaton, W. W., Byrne, M., Ewald, H., Mors, O., Chen, C.-Y., Agerbo, E., & Mortensen, P. B. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.521 · Cited by 527
Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis
Upthegrove, R., Manzanares-Teson, N., & Barnes, N. M. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.03.005 · Cited by 501
Meta-analysis of oxidative stress in schizophrenia.
Flatow, J., Buckley, P., & Miller, B. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.018 · Cited by 491
Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies
Khandaker, G. M., Zimbron, J., Lewis, G., & Jones, P. B. (2012) · Psychological Medicine · doi:10.1017/s0033291712000736 · Cited by 468
Self-citation
NMDA Receptor Blockade by Ketamine Abrogates Lipopolysaccharide-Induced Depressive-Like Behavior in C57BL/6J Mice
Walker, A. K., Budac, D. P., Bisulco, S., Lee, A. W., Smith, R. A., Beenders, B., Kelley, K. W., & Dantzer, R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.71 · Cited by 432
Is Schizophrenia a Progressive Neurodevelopmental Disorder? Toward a Unitary Pathogenetic Mechanism
Woods, B. T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.12.1661 · Cited by 413
Toxoplasma gondii and Other Risk Factors for Schizophrenia: An Update
Torrey, E. F., Bartko, J. J., & Yolken, R. H. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs043 · Cited by 394
Self-citation
Beneficial Antipsychotic Effects of Celecoxib Add-On Therapy Compared to Risperidone Alone in Schizophrenia
Müller, N., Riedel, M. J., Scheppach, C., Brandstätter, B., Sokullu, S., Krampe, K., Ulmschneider, M., Engel, R. R., Möller, H., & Schwarz, M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1029 · Cited by 388
A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia
Levkovitz, Y., Mendlovich, S., Riwkes, S., Braw, Y., Levkovitch-Verbin, H., Gal, G., Fennig, S., Treves, I., & Kron, S. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04666yel · Cited by 387
Assessment of Plasma C-Reactive Protein as a Biomarker of Posttraumatic Stress Disorder Risk
Eraly, S. A., Nievergelt, C. M., Maihofer, A. X., Barkauskas, D. A., Biswas, N., Agorastos, A., O’Connor, D. T., & Baker, D. G. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4374 · Cited by 386
Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers
Maes, M. H. J., Bosmans, E., Calabrese, J. R., Smith, R. S., & Meltzer, H. Y. (1995) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)00049-w · Cited by 385
Increased Prevalence of Diverse N -Methyl-D-Aspartate Glutamate Receptor Antibodies in Patients With an Initial Diagnosis of Schizophrenia
Steiner, J. H., Walter, M., Glanz, W., Sarnyai, Z., Bernstein, H., Vielhaber, S., Kästner, A., Skalej, M., Jordan, W., Schiltz, K., et al. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.86 · Cited by 379
Epidemiology-driven neurodevelopmental animal models of schizophrenia
Meyer, U., & Feldon, J. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.018 · Cited by 378
Schizophrenia: A Subcortical Neurotransmitter Imbalance Syndrome?
Carlsson, M. L., & Carlsson, A. C. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.425 · Cited by 341
Disease-relevant autoantibodies in first episode schizophrenia
Zandi, M. S., Irani, S. R., Lang, B., Waters, P. J., Jones, P. B., McKenna, P. J., Coles, A. J., Vincent, A. C., & Lennox, B. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5788-9 · Cited by 333
Self-citation
The immunoregulatory role of dopamine: An update
Sarkar, C., Basu, B., Chakroborty, D., Dasgupta, P., & Basu, S. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.10.015 · Cited by 323
Developmental plasticity of CNS microglia
Santambrogio, L., Belyanskaya, S. L., Fischer, F., Cipriani, B., Brosnan, C. F., Ricciardi‐Castagnoli, P., Stern, L. J., Strominger, J. L., & Riese, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111152498 · Cited by 309
Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
Akhondzadeh, S., Tabatabaee, M., AMINI, H., Ahmadi-Abhari, S.-A., ABBASI, S., & BEHNAM, B. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.016 · Cited by 290
Signal integration between IFNγ and TLR signalling pathways in macrophages
Schroder, K., Sweet, M. J., & Hume, D. A. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.007 · Cited by 288
Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
Chaudhry, I. B., Hallak, J. E. C., Husain, N., Minhas, F., Stirling, J., Richardson, P., Dursun, S. M., Dunn, G., & Deakin, J. F. W. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444941 · Cited by 284
Self-citation
Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders
Laan, W., Grobbee, D. E., Selten, J., Heijnen, C. J., Kahn, R. S., & Burger, H. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05117yel · Cited by 265
Childhood infection and adult schizophrenia: A meta-analysis of population-based studies
Khandaker, G. M., Zimbron, J., Dalman, C., Lewis, G., & Jones, P. B. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.05.023 · Cited by 257
Self-citation
A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression
Zarate, C. A., Mathews, D., Ibrahim, L., Chaves, J. F., Marquardt, C., Ukoh, I., Jolkovsky, L., Brutsche, N. E., Smith, M. A., & Luckenbaugh, D. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.019 · Cited by 255
Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
Müller, N., Krause, D., Dehning, S., Musil, R., Schennach-Wolff, R., Obermeier, M., Möller, H., Klauß, V., Schwarz, M., & Riedel, M. J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.04.015 · Cited by 252
Immune‐inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine
Maes, M. H. J., Meltzer, H. Y., & Bosmans, E. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01527.x · Cited by 236
Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Gassama, B., Sebastian, D., Buckley, P. F., & Mellor, A. L. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.007 · Cited by 232
Gastrointestinal inflammation and associated immune activation in schizophrenia
Severance, E. G., Alaedini, A., Yang, S., Halling, M., Gressitt, K. L., Stallings, C. R., Origoni, A. E., Vaughan, C., Khushalani, S., Leweke, F. M., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.02.025 · Cited by 228
Self-citation
Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFα or both
Besser, M. J., Ganor, Y., & Levite, M. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.07.013 · Cited by 226
Evidence for an Interaction Between Familial Liability and Prenatal Exposure to Infection in the Causation of Schizophrenia
Clarke, M. C., Tanskanen, A. J., HUTTUNEN, M. O., Whittaker, J. C., & Cannon, M. D. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08010031 · Cited by 218
Psychological effects of ketamine in healthy volunteers
Pomarol‐Clotet, E., Honey, G. D., Murray, G. K., Corlett, P. R., Absalom, A. R., Lee, M., McKenna, P. J., Bullmore, E. T., & Fletcher, P. C. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.105.015263 · Cited by 210
Elevated Maternal C-Reactive Protein and Increased Risk of Schizophrenia in a National Birth Cohort
Canetta, S., Sourander, A., Surcel, H.-M., Hinkka-Yli-Salomäki, S., Leiviskä, J., Kellendonk, C., McKeague, I. W., & Brown, A. S. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13121579 · Cited by 203
Review of immunological and immunopathological findings in schizophrenia.
Rothermundt, M., Arolt, V., & Bayer, T. (2001) · Brain, behavior, and immunity · doi:10.1006/brbi.2001.0648 · Cited by 200
Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci
Andreassen, O. A., Harbo, H. F., Wang, Y., Thompson, W. K., Schork, A. J., Mattingsdal, M., Zuber, V., Bettella, F., Ripke, S., Kelsoe, J. R., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.195 · Cited by 200
Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: Further evidence for disease course-related immune alterations?
Busse, S., Busse, M., Schiltz, K., Bielau, H., Gos, T., Brisch, R., Mawrin, C., Schmitt, A., Jordan, W., Müller, U., et al. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.08.005 · Cited by 195
Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment.
de Witte, L., Tomasik, J., Schwarz, E., Guest, P., Rahmoune, H., Kahn, R., & Bahn, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.02.005 · Cited by 192
Nested Case-control Study
喬, 嶋. (1992) · doi:10.11381/jjcdp1974.26.198 · Cited by 192
Nonsteroidal Anti-Inflammatory Drugs in Schizophrenia
Sommer, I. E., de Witte, L. D., Begemann, M., & Kahn, R. S. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10r06823 · Cited by 182
In vivo immunomodulatory effects of clozapine in schizophrenia
Maes, M. H. J., Bosmans, E., Kenis, G., Jong, R. D., Smith, R. S., & Meltzer, H. Y. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00057-1 · Cited by 178
A peripheral marker for schizophrenia: Increased levels of D 3 dopamine receptor mRNA in blood lymphocytes
Ilani, T., Ben‐Shachar, D., Strous, R. D., Mazor, M., Sheinkman, A., Kotler, M., & Fuchs, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.625 · Cited by 169
Increased serum interleukin-6 levels in early stages of psychosis: Associations with at-risk mental states and the severity of psychotic symptoms
Stojanovic, A., Martorell, L., Montalvo, I., Ortega, L., Monseny, R., Vilella, E., & Labad, J. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.12.005 · Cited by 169
Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system
Carvalho, L. A., Torre, J. P., Papadopoulos, A. S., Poon, L., Juruena, M. F., Markopoulou, K., Cleare, A. J., & Pariante, C. M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.036 · Cited by 167
Neural basis of psychosis-related behaviour in the infection model of schizophrenia
Meyer, U., & Feldon, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.12.022 · Cited by 158
Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease
Nagai, Y., Ueno, S., Saeki, Y., Soga, F., Hirano, M., & Yanagihara, T. (1996) · Neurology · doi:10.1212/wnl.46.3.791 · Cited by 150
Elevated Interleukin-6 in the Cerebrospinal Fluid of a Previously Delineated Schizophrenia Subtype
Garver, D. L., Tamas, R. L., & Holcomb, J. A. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300217 · Cited by 146
Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study
Miyaoka, T., Yasukawa, R., Yasuda, H., Hayashida, M., Inagaki, T., & Horiguchi, J. (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181593d45 · Cited by 146
COX-2 inhibition as a treatment approach in schizophrenia: Immunological considerations and clinical effects of celecoxib add-on therapy
M�ller, N., Ulmschneider, M., Scheppach, C., Schwarz, M., Ackenheil, M., M�ller, H.-J., Gruber, R., & Riedel, M. J. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0478-1 · Cited by 143
Autoimmunity in Schizophrenia: A Review of Recent Findings
Ganguli, R., Brar, J. S., Chengappa, K. N. R., Yang, Z. W., Nimgaonkar, V. L., & Rabin, B. S. (1993) · Annals of Medicine · doi:10.3109/07853899309147317 · Cited by 141
Celecoxib Augmentation of Continuously Ill Patients with Schizophrenia
Rapaport, M. H., Delrahim, K. K., Bresee, C. J., Maddux, R. E., Ahmadpour, O. A., & Dolnak, D. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.024 · Cited by 137
Clinical effects of COX?2 inhibitors on cognition in schizophrenia
M�ller, N., Riedel, M. J., Schwarz, M., & Engel, R. R. (2004) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-004-0548-4 · Cited by 135
Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder
Pearlman, D. M., & Najjar, S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.05.001 · Cited by 123
Peripheral Inflammation Acutely Impairs Human Spatial Memory via Actions on Medial Temporal Lobe Glucose Metabolism
Harrison, N. A., Doeller, C. F., Voon, V., Burgess, N., & Critchley, H. D. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.005 · Cited by 118
Longitudinal Changes in Total Brain Volume in Schizophrenia: Relation to Symptom Severity, Cognition and Antipsychotic Medication
Veijola, J. M., Guo, J. Y., Moilanen, J. S., Jääskeläinen, E., Miettunen, J., Kyllönen, M., Haapea, M., Huhtaniska, S., Alaräisänen, A., Mäki, P. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101689 · Cited by 111
Self-citation
Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties
Zunszain, P. A., Horowitz, M. A., Cattaneo, A., Lupi, M., & Pariante, C. M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.87 · Cited by 110
Identification of Subgroups of Schizophrenia Patients With Changes in Either Immune or Growth Factor and Hormonal Pathways
Schwarz, E., van Beveren, N. J. M., Ramsey, J., Leweke, F. M., Rothermundt, M., Bogerts, B., Steiner, J. H., Guest, P. C., & Bahn, S. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt105 · Cited by 107
Inflammatory Molecular Signature Associated With Infectious Agents in Psychosis
Hayes, L. N., Severance, E. G., Leek, J. T., Gressitt, K. L., Rohleder, C., Coughlin, J. M., Leweke, F. M., Yolken, R. H., & Sawa, A. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu052 · Cited by 106
Self-citation
Possible antipsychotic effects of minocycline in patients with schizophrenia
Miyaoka, T., Yasukawa, R., YASUDA, H., Hayashida, M., Inagaki, T., & Horiguchi, J. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.08.013 · Cited by 105
Antibody-mediated encephalitis: a treatable cause of schizophrenia
Lennox, B., Coles, A. J., & Vincent, A. C. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.095042 · Cited by 97
Self-citation
Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia
Nikkilä, H. V., Müller, K., Ahokas, A., Rimón, R., & Andersson, L. C. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00218-2 · Cited by 95
Elevated C-Reactive Protein Associated With Late- and Very-Late-Onset Schizophrenia in the General Population: A Prospective Study
Wium‐Andersen, M. K., Ørsted, D. D., & Nordestgaard, B. G. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt120 · Cited by 87
Prostaglandin-mediated control of rat brain kynurenic acid synthesis – opposite actions by COX-1 and COX-2 isoforms
Schwieler, L., Erhardt, S., Erhardt, C., & Engberg, G. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0231-y · Cited by 81
Antibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis
Deakin, J., Lennox, B., & Zandi, M. S. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.018 · Cited by 81
Self-citation
Association Between Parental Hospital-Treated Infection and the Risk of Schizophrenia in Adolescence and Early Adulthood
Nielsen, P. R., Laursen, T. M., & Mortensen, P. B. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr149 · Cited by 74
Childhood Epstein-Barr Virus infection and subsequent risk of psychotic experiences in adolescence: A population-based prospective serological study
Khandaker, G. M., Štochl, J., Zammit, S., Lewis, G., & Jones, P. B. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.05.019 · Cited by 71
Self-citation
Über die Liquordiagnose der Schizophrenien
Lehmann-Facius, H. (1937) · Journal of Molecular Medicine · doi:10.1007/bf01776787 · Cited by 63
A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence
Khandaker, G. M., Zammit, S., Lewis, G., & Jones, P. B. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.09.021 · Cited by 63
Self-citation
Psychiatric presentation of voltage-gated potassium channel antibody-associated encephalopathy
Parthasarathi, U. D., Harrower, T., Tempest, M., Hodges, J. R., Walsh, C., McKenna, P. J., & Fletcher, P. C. (2006) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.105.012864 · Cited by 61
Biomarkers of gluten sensitivity in patients with non-affective psychosis: A meta-analysis
LaChance, L., & McKenzie, K. J. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.12.001 · Cited by 54
Neonatal levels of acute phase proteins and later risk of non-affective psychosis
Gardner, R. M., Dalman, C., Wicks, S., Lee, B. K., & Karlsson, H. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.5 · Cited by 48
Adjunct minocycline to clozapine treated patients with persistent schizophrenia symptoms
Kelly, D. L., Vyas, G. R., Richardson, C. M., Koola, M. M., McMahon, R. P., Buchanan, R. W., & Wehring, H. J. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.08.005 · Cited by 44
A variant of the median arcuate ligament syndrome: are sagittal images enough for diagnosis?
Sağlam, M., Sıldıroğlu, H. O., İncedayı, M., Kara, K., & Saygın, H. (2013) · Wiener klinische Wochenschrift · doi:10.1007/s00508-013-0350-2 · Cited by 44
Successful Use of Add-on Minocycline for Treatment of Persistent Negative Symptoms in Schizophrenia
Jhamnani, K., Shivakumar, V., Kalmady, S. V., Rao, N. P., & Venkatasubramanian, G. (2013) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.11120376 · Cited by 40
Abnormal distributions of T-lymphocyte subsets in the cerebrospinal fluid of patients with acute schizophrenia
Nikkilä, H. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00039-b · Cited by 36
Cognitive and Functional Impairment After Severe Sepsis
Khandaker, G. M. (2011) · JAMA · doi:10.1001/jama.2011.142 · Cited by 24
Self-citation
Functional neuroimaging of minocycline's effect in a patient with schizophrenia
Chaves, C., de Marque, C. R., Wichert‐Ana, L., Maia‐de‐Oliveira, J. P., Itikawa, E. N., Crippa, J. A. S., Zuardi, A. W., Todd, K. G., Baker, G. B., Dursun, S. M., et al. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.01.020 · Cited by 23
The effects of celecoxib augmentation on cytokine levels in schizophrenia
Bresee, C. J., Delrahim, K. K., Maddux, R. E., Dolnak, D., Ahmadpour, O. A., & Rapaport, M. H. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005808 · Cited by 20
Non-steroidal anti-inflammatory drugs and the risk of psychosis
Laan, W., Selten, J., Grobbee, D. E., Smeets, H. M., Kahn, R. S., & Burger, H. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.09.003 · Cited by 17
The Association between Exposure to COX-2 Inhibitors and Schizophrenia Deterioration. A Nested Case-Control Study
Stolk, P., Souverein, P. C., Leufkens, H. G. M., Weil, J., Egberts, T. C. G., & Heerdink, E. R. (2007) · Pharmacopsychiatry · doi:10.1055/s-2007-977714 · Cited by 15
A study to evaluate the effect of celecoxib as add-on to olanzapine therapy in schizophrenia
Baheti, T., Nischal, A., Nischal, A., Khattri, S., Arya, A., Tripathi, A., & Pant, K. K. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.03.017 · Cited by 13
Immunologic Therapeutics and Psychotic Disorders
Bullmore, E. T., & Lynall, M.-E. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.12.006 · Cited by 12
Aspirin as an Adjunctive Treatment for Childhood Onset Schizophrenia
Webb, J., Stubbe, D. E., & Poncin, Y. B. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0033 · Cited by 4
Untitled work
(2001) · doi:10.1002/1521-4141(200112)31:12

Sorted by citations

Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
Osimo, E. F., Baxter, L. J., Lewis, G., Jones, P. B., & Khandaker, G. M. (2019) · Psychological Medicine · doi:10.1017/s0033291719001454 · Cited by 774
Self-citation
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders
Sorboni, S. G., Moghaddam, H. S., Esfehani, R. J., & Soleimanpour, S. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00338-20 · Cited by 586
Inflammation in psychiatric disorders: what comes first?
Bauer, M. E., & Teixeira, A. L. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13712 · Cited by 500
A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia
McGuinness, A. J., Davis, J. A., Dawson, S. L., Loughman, A., Collier, F., O’Hely, M., Simpson, C. A., Green, J., Marx, W., Hair, C., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01456-3 · Cited by 502

See all 931

Authors: Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B.
Affiliations: University of Cambridge (GB)
University of Oxford (GB)
Johns Hopkins University (US)
ORCID: Khandaker, Golam M
Cousins, Lesley
Lennox, Belinda R
Yolken, Robert
Jones, Peter B
Venue: The Lancet Psychiatry
Publisher: Elsevier BV
Published: 2015-03
Volume: 2
Issue: 3
Pages: 258-270
ISSN: 2215-0366 (ISSN-L)
DOI: 10.1016/s2215-0366(14)00122-9
PMC: PMC4595998
OpenAlex: W2121637331
Cited by: 926
References: 135
Citations by year: 2026: 82 · 2025: 81 · 2024: 111 · 2023: 104 · 2022: 94 · 2021: 105 · 2020: 78 · 2019: 86 · 2018: 62 · 2017: 63 · 2016: 54 · 2015: 5
FWCI: 3.45
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet Psychiatry (publishedVersion)
PubMed (publishedVersion)
Bristol Research (University of Bristol) (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Apollo (University of Cambridge) (acceptedVersion)
Explore Bristol Research (submittedVersion)
Funders: Wellcome Trust to GMK ((094790/Z/10/Z; 2010-'13))
National Institute of Mental Health ((MH-94268))
Wellcome Trust ((095844/Z/11/Z and 088869/Z/09/Z))
National Institute for Health Research ((RP-PG-0606–1335))
Topics: Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: schizophrenia, inflammation, immunity, innate immune response, adaptive immune response, infection, blood-brain barrier, anti-inflammatory agents, psychosis, pathophysiology, treatment
MeSH terms: Humans, Immune System, Inflammation, Schizophrenia, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks